Company news
Annovis Bio, Inc. news in 2025
Annovis Bio, Inc.'s news releases, calls and decks from 2025, newest first.
Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients
December 18, 2025
Annovis to Host Corporate Update Webinar on January 28, 2026
December 16, 2025
Annovis To Present at the 2025 Annual Meeting of the Parkinson Study Group
December 3, 2025
Annovis Announces Two Presentations at the CTAD 2025 Conference
November 24, 2025
Annovis Announces FDA Meeting to Discuss Parkinson's Disease Dementia Program; Reaffirms FDA Alignment on Pivotal Phase 3 Alzheimer's Disease Study
November 18, 2025
Annovis Reports New Biomarker Data Linking Amyloid Co-Pathology to Accelerated Cognitive Decline in Parkinson's Patients
November 17, 2025
Annovis Provides Corporate Updates and Reports Third Quarter 2025 Financial Results
November 12, 2025
Annovis Achieves Significant Milestones and Sustains Strong Progress in Phase 3 Alzheimer’s Program
November 6, 2025
Annovis Announces $3.4 Million Registered Direct Offering of Common Stock Priced At-the-Market under the NYSE Rules
October 27, 2025
Annovis Announces Closing of $6 Million Registered Direct Offering of Common Stock
October 15, 2025
Annovis Announces $6 Million Registered Direct Offering of Common Stock
October 10, 2025
Annovis Announces Novel Biomarker Data in Alzheimer’s Patients Supporting Buntanetap’s Potential as a Disease-Modifying Treatment
October 9, 2025
Annovis Appoints Mark Guerin as Chief Financial Officer
September 25, 2025
Annovis Reports Peer-Reviewed Publication Highlighting Pharmacokinetics of Novel Crystal Buntanetap
September 16, 2025
Annovis to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 2, 2025
Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results
August 12, 2025
Annovis Completes Full Patent Transfer to Crystal Buntanetap
August 7, 2025
Annovis to Attend the AAIC 2025 with Four Poster Presentations
June 26, 2025
Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance
June 19, 2025
Annovis to Host Webinar and Live Q&A on June 24, 2025
June 5, 2025
Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results
May 13, 2025
Annovis Bio Appoints Hui Liu as Director of Biostatistics
April 29, 2025
Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE
March 27, 2025
Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program
March 25, 2025
Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
March 21, 2025
Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment
March 11, 2025
Annovis to Host Patients’ Live Forum on February 27, 2025
February 19, 2025